These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29175897)

  • 1. Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.
    Barbosa PM; Grippe T; Lees AJ; O'Sullivan S; Djamshidian A; Warner TT
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1121-1123. PubMed ID: 29175897
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease.
    Walker RW; Howells AR; Gray WK
    Parkinsonism Relat Disord; 2011 Jan; 17(1):27-9. PubMed ID: 21051272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Parkinson's disease therapy improved punding but not feeling of presence.
    Aquino CC; Celso de Castro P; Doná F; Medeiros L; Silva SM; Borges V; Ferraz HB
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E43-4. PubMed ID: 24026740
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinson's disease: recent advances in therapy.
    Jankovic J
    South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
    [No Abstract]   [Full Text] [Related]  

  • 6. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
    Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there addiction to levodopa in patients with Parkinson's disease?
    Merims D; Galili-Mosberg R; Melamed E
    Mov Disord; 2000 Sep; 15(5):1014-6. PubMed ID: 11009217
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease.
    Burn DJ
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):240. PubMed ID: 12185151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficiency of new forms of madopar in Parkinson's disease].
    Vendrova MI; Sadekov RA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
    [No Abstract]   [Full Text] [Related]  

  • 11. Sinemet CR in Parkinson's disease.
    Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
    Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings.
    Neurology; 1989 Nov; 39(11 Suppl 2):1-106. PubMed ID: 2586761
    [No Abstract]   [Full Text] [Related]  

  • 13. Asparagus and jejunal-through-PEG: an unhappy encounter in intrajejunal levodopa infusion therapy.
    Schrader C; Böselt S; Wedemeyer J; Dressler D; Weismüller TJ
    Parkinsonism Relat Disord; 2011 Jan; 17(1):67-9. PubMed ID: 20933456
    [No Abstract]   [Full Text] [Related]  

  • 14. Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Benincasa D; Pellicano C; Fanciulli A; Pontieri FE
    Mov Disord; 2011 Feb; 26(2):355-7. PubMed ID: 21412840
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical treatment of Parkinson's disease.
    Ahlskog JE
    Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].
    Szász JA; Szatmári S; Constantin V; Mihály I; Rácz A; Domokos LC; Vajda T; Orbán-Kis K
    Orv Hetil; 2019 Apr; 160(17):662-669. PubMed ID: 31010306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD; Ismail HA; Frank C
    Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled-release carbidopa/levodopa in the treatment of Parkinsonism.
    Hutton JT; Dippel RL; Bianchine JR; Strahlendorf HK; Meyer PG
    Clin Neuropharmacol; 1984; 7(2):135-9. PubMed ID: 6375861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimisation of treatment of Parkinson's disease with levodopa].
    Białecka M; Adamiak U; Gawrońska-Szklarz B
    Neurol Neurochir Pol; 2009; 43(5):446-59. PubMed ID: 20054747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for Parkinson's disease.
    Simonson W
    Geriatr Nurs; 2017; 38(3):244-245. PubMed ID: 28552205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.